Study of Angiocal® in Patients With Solid Tumors, Investigating Safety, Tolerability, Blood Concentration of Study Drug
Clinical trial NCT01141257 · COMPLETED
Trial details
- NCT number
- NCT01141257
- Sponsor
- Pieris Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2011-09-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.